Etoricoxib 60mg + Pregabalin 75mg PR Tablets

Etoricoxib 60mg + Pregabalin 75mg tablet is used for selected mixed-pain conditions with both inflammatory and neuropathic features. It combines an anti-inflammatory medicine with treatment directed at abnormal nerve signalling.
Swallow the prolonged-release tablet whole with water; do not crush or chew it. Keep doses on the planned schedule. Avoid alcohol and do not drive if sleepy or dizzy. After regular pregabalin treatment, stopping requires gradual reduction to limit withdrawal symptoms; do not abruptly discontinue it when pain first improves.
Etoricoxib reduces inflammatory prostaglandins through COX-2 inhibition. Pregabalin reduces abnormal nerve excitability by binding alpha-2-delta calcium-channel subunits.
Possible effects include sleepiness, dizziness, blurred vision, swelling, weight gain, dry mouth, constipation, indigestion, nausea, raised blood pressure, and headache. Serious warning signs include mood changes, severe drowsiness, breathing difficulty with sedatives/opioids, chest pain, black stools, or reduced urination.
Tell your doctor about kidney or heart disease, high blood pressure, depression, substance-use problems or swelling. Mention pregnancy, breastfeeding, alcohol, opioids, sedatives, blood thinners and other NSAIDs. Older adults may be more vulnerable to dizziness and sedation. Avoid NSAIDs from 20 weeks of pregnancy unless specifically necessary under obstetric supervision, and avoid them from 30 weeks because of fetal kidney and heart risks.
Targets two pain pathways: inflammation and abnormal nerve signalling, which may help selected mixed-pain conditions.
Etoricoxib 60mg + Pregabalin 75mg is used for selected pain conditions where both inflammatory and nerve-pain mechanisms are being treated.
Yes. Pregabalin can cause drowsiness, dizziness, and blurred vision.
If taken regularly, pregabalin-containing therapy should usually be tapered under medical advice.
Alcohol can increase sleepiness, impaired coordination, and stomach/liver risks.
Severe drowsiness, breathing trouble, mood changes, chest pain, black stools, or reduced urine needs review.
Neuropathic pain: pain caused by damage or disease affecting nerves. COX-2 inhibitor: a selective anti-inflammatory medicine class. Alpha-2-delta subunit: a calcium-channel component targeted by pregabalin. Sedation: reduced alertness or sleepiness. Tapering: gradual dose reduction.; AR: Etoricoxib 60mg + Pregabalin 75mg PR أقراص; FR: Etoricoxib 60mg + Pregabalin 75mg PR comprimé; PT: Etoricoxib 60mg + Pregabalin 75mg PR comprimido; ES: Etoricoxib 60mg + Pregabalin 75mg PR tableta; RU: Etoricoxib 60mg + Pregabalin 75mg PR таблетки; ID: Etoricoxib 60mg + Pregabalin 75mg PR tablet; VI: Etoricoxib 60mg + Pregabalin 75mg PR viên nén; MS: Etoricoxib 60mg + Pregabalin 75mg PR tablet; TL: Etoricoxib 60mg + Pregabalin 75mg PR tableta; ZH-SG: Etoricoxib 60mg + Pregabalin 75mg PR 片剂
International B2B Enquiry
Send a structured B2B enquiry for Etoricoxib 60mg + Pregabalin 75mg PR Tablets under Pain Relief. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Etoricoxib 60mg + Pregabalin 75mg PR Tablets